Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
23.90
-0.09 (-0.38%)
At close: Apr 24, 2026, 4:00 PM EDT
24.00
+0.10 (0.42%)
After-hours: Apr 24, 2026, 4:17 PM EDT
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $4.42 billion as of April 24, 2026. Its market cap has decreased by -21.78% in one year.
Market Cap
4.42B
Enterprise Value
3.94B
1-Year Change
-21.78%
Ranking
Category
Stock Price
$23.90
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from $4.79B to $4.42B, a decrease of -7.65%. That is a compound annual growth rate of -1.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 4.44B | 10.50% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xenon Pharmaceuticals | 5.29B |
| Apellis Pharmaceuticals | 5.24B |
| Dianthus Therapeutics | 4.89B |
| Corcept Therapeutics | 4.84B |
| Ligand Pharmaceuticals | 4.56B |
| Amicus Therapeutics | 4.54B |
| Crinetics Pharmaceuticals | 4.03B |
| Viking Therapeutics | 3.80B |